Company
Meritage Pharma
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Meritage Pharma is committed to the development of prescription products based on safe and effective molecules for the treatment of gastrointestinal and atopic diseases. Meritage Pharma’s initial product candidate is intended for the treatment of eosinophilic esophagitis, an allergic inflammation of the esophagus. The company is enrolling a clinical trial of oral budesonide suspension for the treatment of eosinophilic esophagitis. The trial is expected to be completed in 2014.
Loading relationship preview